Navigation Links
Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
Date:1/12/2009

HOPKINTON, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. today announced that on January 8, 2009, it received notice from the NASDAQ Stock Market ("NASDAQ") that for the last 10 consecutive trading days, the market value of its listed securities has been below the minimum $35 million requirement for continued inclusion under NASDAQ Marketplace 4310(c)(3)(B). Furthermore, NASDAQ stated that the Company does not comply with NASDAQ Marketplace Rule 4310(c)(3)(A) or 4310(c)(3)(C), which requires the Company to have either minimum stockholders' equity of $2.5 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO )

In accordance with NASDAQ Marketplace Rule 4310(c)(8)(C), the Company was provided thirty calendar days, or until February 9, 2009 (the "Compliance Period"), to regain compliance. This requires, at a minimum, that the market value of listed securities of the Company's common stock remain $35,000,000 or more for a minimum of 10 consecutive business days at anytime prior to February 9, 2009.

If the Company does not regain compliance within the Compliance Period, NASDAQ will provide the Company with written notification that the Company's common stock will be delisted from the NASDAQ Capital Market. At that time, the Company may appeal the determination by the NASDAQ Staff to delist its common stock to a Listing Qualifications Panel. The Company is currently considering actions that may allow it to regain compliance with the NASDAQ continued listing standards and maintain its NASDAQ listing. There is no assurance that the Company will be able to take any of these actions or that any of the actions will be sufficient to allow the Co
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
4. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
7. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
8. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
9. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
10. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
11. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... ... 2015 , ... The Erie County Bar Association Institute of ... Association welcomed speaker C. Daniel McGillicuddy Esq. of William Mattar Law Offices. ... these types of cases. , Each year, New York State residents are hospitalized ...
(Date:7/3/2015)... ... July 03, 2015 , ... " Selfie on a Stick ... the latest and coolest technology products available to consumers. Amanda Forstrom, a technology expert ... selfie sticks are great for documenting memories. , Almost every smartphone has an incredibly ...
(Date:7/2/2015)... ... ... pleased to announce the opening of its newest location in Dallas, Texas. The opening is ... chain was listed as #22 on the Inc. 500 list of fastest growing companies in ... located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , “We are excited ...
(Date:7/2/2015)... ... , ... Many Fourth of July celebrations will include fireworks this summer, so ... sharing some tips to promote the proper use of fireworks. , According to the ... daily with fireworks-related injuries in the month surrounding the Fourth of July. Amica is ...
(Date:7/2/2015)... CITY, GA (PRWEB) , ... July 02, 2015 ... ... field sporting the newest shades of the SIGVARIS PERFORMANCE SOCKS. Since the socks ... fitness experts and athletic trainers. Their significant popularity has inspired four new, fun ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2
... supply for the ... healthcare industry, OTTAWA, Oct. ... radiopharmaceuticals, signed a 17-year,contract for the supply of cobalt-60 with Rosenergoatom, ... the,2005 agreement by providing for an increased supply of cobalt-60 to ...
... New Non-Steroidal Skin Treatment to Treat All ... with Steroids, BARRINGTON, Ill., Oct. 19 Steroids have ... abuse. There must be reasons why,people use steroid products on ... largest organ of the human body, and it needs to ...
... 19 VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH), ... developing and,commercializing targeted cancer therapeutics, announced today ... presentations pertaining to VQD-002 (TCN-PM),and Lenocta(TM) (SSG) ... Conference sponsored by the American Association for ...
... per month, experts say , FRIDAY, Oct. 19 (HealthDay News) ... severe kidney disease could help improve patients, quality of life, ... giving patients an anti-anemia drug as infrequently as once a ... the Renal Research Institute in New York, and colleagues. , ...
... Earnings Per Share Exceeds Guidance -, EXTON, Pa., Oct. ... the results for its first quarter of fiscal,year 2008. ... which include net sales,and royalty income, were $17.6 million in ... $16.3 million in the prior year first quarter. Net ...
... Israel, October 19 Healthcare,Technologies Ltd. (NASDAQ: HCTL ... shareholders, previously scheduled for September 30,2007, will be held ... offices of,Yigal Arnon & Co., 1 Azrieli Center, Round ... shareholders will be asked to approve the previously,announced Asset ...
Cached Medicine News:Health News:MDS Nordion signs 17-year contract with Rosenergoatom 2Health News:Steroids Are Abused for Skin, Not Just Muscles 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 2Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 3Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 4Health News:VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting 5Health News:Simpler Anemia Treatment May Help Kidney Patients 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 2Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 3Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 4Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 5Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 6Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 7Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 8Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 9Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 10Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 11Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 12Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 13Health News:Kensey Nash Reports First Quarter Fiscal Year 2008 Results 14Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 2Health News:Healthcare Technologies Announces New Date for the Shareholders Meeting to Approve the Nexgen Biofuels Transaction 3
(Date:7/3/2015)... Redwood Pharma AB has entered ... operating in both the US and China ... supramolecular hydrogel technology in its lead chronic Dry ... The Broda technology offers many unique competitive benefits. At ... and with low concentrations of polymer the system can ...
(Date:7/2/2015)... TX and VANCOUVER , July ... "Company") (TSX-V: EPI) announced today that its common shares have ... Market ("NASDAQ") under the symbol "EPIX". ESSA will ... will retain its listing on the TSX Venture Exchange under ... listing of the common shares on the NASDAQ, each of ...
(Date:7/2/2015)...  Before you head outdoors with your family to enjoy ... and healthy. Take steps to protect yourself from the sun, ... Protect Your Skin From the Sun Exposure ... risk of skin cancer. To protect your skin from UV ... during midday hours. Wear a hat with a wide brim ...
Breaking Medicine Technology:Redwood Pharma Licenses Novel Hydrogel Drug Delivery Technology From Broda Technologies 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4First Aid Summer Survival Tips from Nyack Hospital 2First Aid Summer Survival Tips from Nyack Hospital 3
... Sept. 17 Optovue, the company that launched the ... announced that it has received 510(k) clearance on its ... "This affirms that our protocols and management of ... level that FDA regulatory guidelines require," stated Mike Sinai, ...
... Medical, Inc., a leading innovator of noninvasive physiological monitoring ... the 1000USB-C USB adapter. Designed for OEM system developers, ... to conveniently transfer secure data in accordance with Continua ... a line of USB adapters released by Nonin this ...
Cached Medicine Technology:Optovue Receives FDA Clearance on OCT Normative Database 2Nonin Medical Announces Continua™ Certified USB Data Transfer Device for Its Handheld Oximeter Line 2
Intermittent catheter...
Enhanced drug and formulary reference with integrated ID treatment guide and tools. Increase patient safety and satisfaction with our premium drug reference....
... Flexible Band is a flexible partial ... alternative for surgeons who desire posterior ... Tailor® Annuloplasty Ring, which is designed ... rings, but like the option of ...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (Z71,407-0) or contact custom...
Medicine Products: